Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Woodland International Research Group is a U.S. clinical research site in Little Rock, Arkansas that conducts sponsor-funded clinical trials for new and existing drugs. The organization historically focused on psychiatric research and has expanded into broader medical studies, with stated experience in CNS, pain, addiction, GI, cardiology, infectious disease, and other therapeutic areas. It operates an inpatient clinical research unit with pediatric, adult, and elderly study capabilities and supports specialized trial procedures such as serial pharmacokinetic sampling and sleep-study assessments. Woodland is presented as part of the Evolution Research Group network and serves sponsors, CROs, and trial participants rather than developing its own proprietary drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Woodland International Research Group.